Raman Spectroscopy and AI for Brain Tumor Diagnosis

Disclosure(s):

Daniel Orringer, MD: Designs for Vision: Consultant (Terminated); Imagenomix: Stock Shareholder (excluding mutual funds) (Ongoing); Invenio: Advisor (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing); Medexus: Consultant (Terminated); NXDC: Consultant (Terminated); Stryker: Consultant (Ongoing)